249
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Modulating Blood-Brain Barrier Interactions of Amino Acid-Based Anticancer Agents

, &
Pages 21-25 | Published online: 29 Sep 2008

References

  • Amsberry, K. L., and Borchardt, R. T. 1991. Amine prodrugs which utilize hydroxy amide lactonization. II. A potential redox-sensitive amide prodrug. Pharm. Res. 9:323–330.
  • Bodor, N., Sloan, K. B., Higuchi, T., and Sasahara, K. 1977. Improved drug delivery through biological membranes. 4. Prodrugs of L-dopa. J. Med. Chem. 20:1435–1445.
  • Brightman, M. W., and Reese, T. S. 1969. Junctions between intimately opposed cell membranes in vertebrate brain. J. Cell Biol. 40:648–677.
  • Carpino, L. A., Triolo, S. A., and Berglund, R. A. 1989. Reductive lactonization of strategically methylated quinone propionic acid esters and amides. J. Org. Chem. 54:3303–3310.
  • Chikhale, E. G., Chikhale, P. J., and Borchardt, R. T. 1995. Carrier-mediated transport of the anti-tumor agent acivicin across the blood-brain barrier. Biochem. Pharmacol. 49:941–945.
  • Crone, C., and Levitt, D. G. 1984. Capillary permeability to small solutes. In Handboo k of Physiology, eds. E. M. Renkin and C. C. Michel, 411–466. Bethesda, MD: American Physiological Society.
  • Gharat, L., Visser, P., Brummelhuis, M., Guiles, R., and Chikhale, P. J. 1998. Re- ductive activation of conformationally-constraine d anticancer drug delivery systems. Med. Chem. Res. 8:444–456.
  • Greig, N. H., Momma, S., Sweeney, D. J., Smith, Q. R., and Rapoport, S. I. 1987. Facilitated transport of melphalan at the rat blood-brai n bar- rier by the large neutral amino acid carrier system. Cancer Res. 47:1571–1576.
  • Oldendorf, W. H. 1971. Brain uptake of radiolabeled amino acids, amines and hexoses after arterial injection. Am. J. Physiol. 221:1629–1639.
  • Rachele, J. R. 1963. The methyl esterification of amino acids with 2,2- dimethoxypropan e and aqueous hydrogen chloride. J. Org. Chem. 28:2898.
  • Sasiela, C. A., Killian, D., and Chikhale, P. 1998. Bioreductively-activate d drug delivery systems designed to optimize solid tumor targeting and avoid neurotoxicity. Proc. Amer. Assoc. Cancer Res. 39:426.
  • Smith, Q. R., Takasato, Y., Sweeney, D. J., and Rapoport, S. I. 1985. Regional cerebrovascula r transport of leucine as measured by the in situ brain perfusion technique. J. Cereb. Blood Flow 5:300–311.
  • Smith, Q. R., Momma, S., Aoyagi, M., and Rapoport, S. I. 1987. Kinetics of neutral amino acid transport across the blood-brain barrier. J. Neuroche m. 49:1651–1658.
  • Takada, Y., Greig, N. H., Vistica, D. T., Rapoport, S. I., and Smith, Q. R. 1991. Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrier. Cancer Chemother. Pharmacol. 29:89– 94.
  • Takasato, Y., Rapoport, S. I., and Smith, Q. R. 1984. An in situ brain perfu- sion technique to study cerebrovascula r transport in the rat. Am. J. Physiol. 247:H484–H493.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.